TriSalus Life Sciences Income from Continuous Operations 2021-2024 | TLSI
TriSalus Life Sciences income from continuous operations from 2021 to 2024. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
| TriSalus Life Sciences Annual Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2023 | $-59 |
| 2022 | $-47 |
| 2021 | $5 |
| 2020 | $-1 |
| TriSalus Life Sciences Quarterly Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2024-09-30 | $-2 |
| 2024-06-30 | $-4 |
| 2024-03-31 | $-13 |
| 2023-12-31 | $-35 |
| 2023-09-30 | $-1 |
| 2023-06-30 | $-14 |
| 2023-03-31 | $-8 |
| 2022-12-31 | $-44 |
| 2022-09-30 | $-8 |
| 2022-06-30 | $2 |
| 2022-03-31 | $3 |
| 2021-12-31 | $3 |
| 2021-09-30 | $2 |
| 2021-06-30 | $0 |
| 2021-03-31 | $-0 |
| 2020-12-31 | |
| 2020-09-30 | $-0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.156B | $0.019B |
| TriSalus Life Sciences Inc. is an oncology company integrating immunotherapy with disruptive delivery technology to transform the treatment paradigm for patients with liver and pancreatic tumors. TriSalus Life Sciences Inc., formerly known as MedTech Acquisition Corporation, is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $221.889B | 27.39 |
| Boston Scientific (BSX) | United States | $150.861B | 43.37 |
| Stryker (SYK) | United States | $149.166B | 32.10 |
| EssilorLuxottica (ESLOY) | France | $125.458B | 0.00 |
| Medtronic (MDT) | Ireland | $116.457B | 17.30 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.799B | 0.00 |
| Agilent Technologies (A) | United States | $43.273B | 28.64 |
| Haleon (HLN) | United Kingdom | $42.868B | 27.85 |
| GE HealthCare Technologies (GEHC) | United States | $40.342B | 20.92 |
| ResMed (RMD) | United States | $34.670B | 26.72 |
| Terumo (TRUMY) | Japan | $27.627B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $25.924B | 19.84 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.795B | 13.88 |
| Insulet (PODD) | United States | $19.527B | 77.76 |
| Baxter (BAX) | United States | $16.625B | 10.82 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.096B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $10.103B | 34.34 |
| Sunny Optical Technology (SNPTF) | China | $9.976B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.961B | 40.08 |
| Demant (WILYY) | Denmark | $8.994B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.432B | 14.94 |
| ICU Medical (ICUI) | United States | $4.024B | 38.31 |
| Prestige Consumer Healthcare (PBH) | United States | $3.793B | 18.86 |
| Envista Holdings (NVST) | United States | $3.531B | 26.31 |
| Haemonetics (HAE) | United States | $3.468B | 16.92 |
| Perrigo (PRGO) | Ireland | $3.398B | 10.00 |
| GN Store Nord (GNNDY) | Denmark | $3.105B | 19.91 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $2.989B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.923B | 18.81 |
| Neogen (NEOG) | United States | $2.486B | 28.65 |
| LeMaitre Vascular (LMAT) | United States | $2.179B | 52.97 |
| AtriCure (ATRC) | United States | $1.944B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.483B | 25.96 |
| AdaptHealth (AHCO) | United States | $1.456B | 10.40 |
| InMode (INMD) | Israel | $1.445B | 8.69 |
| BioLife Solutions (BLFS) | United States | $1.267B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.245B | 0.00 |
| Owens & Minor (OMI) | United States | $1.098B | 8.58 |
| Evolus (EOLS) | United States | $0.885B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.883B | 15.58 |
| Curaleaf Holdings (CURLF) | Canada | $0.866B | 0.00 |
| CeriBell (CBLL) | United States | $0.824B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.684B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.567B | 24.98 |
| Omeros (OMER) | United States | $0.500B | 0.00 |
| Surmodics (SRDX) | United States | $0.487B | 0.00 |
| Valneva SE (VALN) | France | $0.470B | 0.00 |
| SNDL (SNDL) | Canada | $0.457B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.454B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.449B | 0.00 |
| ZimVie (ZIMV) | United States | $0.382B | 32.19 |
| Quanterix (QTRX) | United States | $0.354B | 0.00 |
| Cerus (CERS) | United States | $0.347B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.319B | 30.33 |
| Sanara MedTech (SMTI) | United States | $0.318B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.300B | 20.10 |
| Biote (BTMD) | United States | $0.277B | 6.06 |
| Canopy Growth (CGC) | Canada | $0.260B | 0.00 |
| Zynex (ZYXI) | United States | $0.250B | 52.27 |
| Sanuwave Health (SNWV) | United States | $0.237B | 3.33 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.226B | 0.00 |
| High Tide (HITI) | Canada | $0.226B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.208B | 15.50 |
| Aurora Cannabis (ACB) | Canada | $0.200B | 0.00 |
| Brainsway (BWAY) | Israel | $0.198B | 105.10 |
| Organigram Holdings (OGI) | Canada | $0.189B | 0.00 |
| MacroGenics (MGNX) | United States | $0.188B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.168B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.141B | 17.76 |
| Quipt Home Medical (QIPT) | United States | $0.139B | 0.00 |
| Jin Medical (ZJYL) | China | $0.138B | 0.00 |
| Fonar (FONR) | United States | $0.100B | 11.25 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.090B | 0.00 |
| Veru (VERU) | United States | $0.081B | 0.00 |
| InterCure (INCR) | Israel | $0.074B | 0.00 |
| Exagen (XGN) | United States | $0.071B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.066B | 34.00 |
| Jushi Holdings (JUSHF) | United States | $0.065B | 0.00 |
| INLIF (INLF) | $0.062B | 0.00 | |
| Ayr Wellness (AYRWF) | United States | $0.056B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.055B | 0.00 |
| Apyx Medical (APYX) | United States | $0.054B | 0.00 |
| United-Guardian (UG) | United States | $0.053B | 15.18 |
| Modular Medical (MODD) | United States | $0.052B | 0.00 |
| ImmuCell (ICCC) | United States | $0.048B | 0.00 |
| Safety Shot (SHOT) | United States | $0.030B | 0.00 |
| Nephros (NEPH) | United States | $0.017B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.016B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.015B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.011B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.001B | 0.00 |
| Sharps Technology (STSS) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |